RxCelerate
Cambridge, United Kingdom rxcelerate.com From their website, Nov 2026
Work here? Claim this listing
About
RxCelerate is a drug discovery and development company based in Cambridge, UK, with an additional location in Cambridge, Massachusetts, USA. It works with biotech and other life science clients on bespoke programs from in silico discovery through preclinical research and toward clinical development.
Services
Programme design and management
Designs and manages bespoke drug discovery and development programmes.
In silico drug design
Uses in silico methods for small-molecule and protein design, including rapid screening with RxPlorer™ and RxNfinity™.
Antibody discovery and development
Generates and develops antibodies using the Galaxy® platform, including humanisation, immune library generation, and bispecific generation.
Proteomics services
Provides ProQuant® proteomics workflows for quantitative analysis of proteins, post-translational modifications, biomarkers, chemoproteomics, and biologics characterization.
Chemistry
Provides medicinal chemistry, compound design, synthesis management, complex synthesis, ADC linker and payload design, controlled drug handling, and CMC management.
Biology
Supports biology-led discovery and optimization through in vitro and in vivo work across drug discovery and preclinical stages.
In vitro antibody characterisation
Runs target engagement, internalisation, T cell activation, and Fc effector function assays for antibody characterization.
Functional cell based assays
Develops and runs cell-based assays to support discovery and mechanism-of-action work.
15 more services
- Immunoassays
- Molecular and biochemical assays
- Multi-colour flow cytometry
- Protein-protein interactions
- Drosophila
- Preclinical histology
- ADME and DMPK
- Experimental medicine
- Project management
- In silico design of small molecules and proteins
- Proteomics platform
- In vitro assays and development
- In vivo assays and development
- Chemistry – both early stage and CMC
- DMPK studies
- Lead time
- Within a matter of weeks
- What to send
- Periplasmic preps
- Recombinant target protein
- Cell lines
- Tissues
- Plasma
Capabilities
- Processes
- Small molecule
- Antibody
- Bispecific
- ADC
- Flow cytometry
- Cell-based assays
- ADME
- In vivo
- Capacity
- 384-well plate
- >6000 proteins in tissues
Equipment
- Multi-colour flow cytometry
- ImageStream
Materials
- Primary human cells
Industries served
- Biotech
- Life science
Company
- Type
- CRO
- Founded
- 2013
- Quality
- UK Home Office controlled drugs license (handle controlled substances for research purposes)
Locations
- Based in
- Cambridge, United Kingdom
- Sites
- Cambridge, MA, USA
- Serves
- UK, USA
- MHRA GLP site
- Rxcelerate Limited, Cambridge, GB source
Contacts
- Phone
- +44 (0)1223 839557